2013 annual financial data

Amphastar Pharmaceuticals 2013 Net margin

Amphastar Pharmaceuticals 2013 net margin with verified reported values.

Direct answer

Net margin was 5.16%.

Operating income was 17,490,000 USD and net income was 11,862,000 USD.
Operating cash flow was 31,042,000 USD.

Get free Amphastar Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
229,681,000 USD
Operating income
17,490,000 USD
Net income
11,862,000 USD
Operating cash flow
31,042,000 USD